Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Shares of Cardinal Health Inc. CAH advanced 1.82% to $127.45 Wednesday, on what proved to be an all-around great trading ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...

Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Apyx ...

Healthcare Distribution Market is expected to reach USD 1,633.1 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031. BURLINGAME, CA, UNITED STATES, January 22 ...

I knew deep winter had arrived when the first seed catalog showed up in the mail. These winter missives were really harbingers of spring, with their glossy photos of plump tomatoes just begging to be ...

Dr. Jeff Wessler (MD MPhil FACC) is a virtual cardiologist, the Founder of Heartbeat Health, and on clinical faculty at Northwell Health. The year 2025 looms large for healthcare—a field ...

Global healthcare spending is $9.8 trillion; the U.S. accounts for about $4.9 trillion. Investors should evaluate the growth prospects, financial strength, valuation, and dividends of healthcare ...

COLUMBUS, Ohio (COLUMBUS BUSINESS FIRST) — Cardinal Health Inc. raised its earnings outlook for fiscal 2025 for the second time in the first half of the year. Ahead of CEO Jason Hollar’s ...